Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone in severe acute phosphide poisoning
PACTR201811766698931Phase 2Completed
- Sponsor
- Tanta University
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of hydrocortisone in Phosphide poisoning (2 arms), sponsored by Tanta University. Primary endpoint: Mortality. Started Sep 2016; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Phosphide poisoning
Beyond the preview
Go deeper on PACTR201811766698931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201811766698931.